Pagel, Inc. v. Commissioner

91 T.C. No. 18, 91 T.C. 200, 1988 U.S. Tax Ct. LEXIS 102
CourtUnited States Tax Court
DecidedAugust 8, 1988
DocketDocket No. 34122-85
StatusPublished
Cited by69 cases

This text of 91 T.C. No. 18 (Pagel, Inc. v. Commissioner) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pagel, Inc. v. Commissioner, 91 T.C. No. 18, 91 T.C. 200, 1988 U.S. Tax Ct. LEXIS 102 (tax 1988).

Opinion

WELLS, Judge:

Respondent determined a deficiency in petitioner’s Federal income tax for the year ending March 31, 1982, in the amount of $195,782.54. After concessions, the remaining issue is whether petitioner realized capital gain or ordinary income upon the sale by petitioner to its sole shareholder of a warrant to purchase stock in another corporation.

PRELIMINARY MATTER

When the instant case was reached for trial, .the parties had settled all but two of the items raised in the notice of deficiency. Trial then proceeded with respect to the issues involving those two items — the characterization and timing of the income attributable to a warrant for the purchase of stock in Immuno Nuclear Corp., and a warrant for the purchase of stock in FilmTec Corp. The parties then filed simultaneous briefs and simultaneous reply briefs. In his reply brief, respondent stated that he “concedes the portion of the tax deficiency arising from the FilmTec warrant for purposes of this litigation. Respondent makes this concession without waiving its right to pursue the conceded portion through appropriate tax assessment procedures for the [year ending March 31, 1985].”

Although respondent’s reply brief proffered to concede a significant portion of the deficiency for the year before us (ending March 31, 1982), petitioner filed a supplemental reply brief requesting the Court to render a decision on the merits and not to accept respondent’s concession.1 Petitioner, however, has cited no authority to support a rejection of respondent’s proffered concession. Petitioner objects to respondent’s offer of concession on the following grounds:

Respondent’s shifting positions are prejudicial to the Petitioner. Petitioner has fully liquidated and is in the process of dissolving itself. It has retained only enough assets to pay any judgment in the pending Tax Court matter. It will not have sufficient assets to defend and pay a large judgment based upon the value of the warrant at the time of exercise.

The acceptance or rejection of a proffered concession is a matter within the discretion of the Court, and we should exercise our discretion in accordance with the “interest of justice.” See Jones v. Commissioner, 79 T.C. 668, 673 (1982); McGowan v. Commissioner, 67 T.C. 599, 607 (1976). Petitioner has not suggested how the interest of justice would compel us to reject respondent’s offer of concession, and we can conceive of no injustice in allowing petitioner to prevail as to the portion of the deficiency relating to the FilmTec warrant. We therefore accept respondent’s concession on that issue and shall proceed to our decision on the final item — the Immuno Nuclear Corp. warrant.

FINDINGS OF FACT

Some of the facts have been stipulated and are found accordingly. The stipulation of facts and attached exhibits are incorporated herein by this reference.

During all relevant periods, petitioner was a corporation having its principal place of business in Minneapolis, Minnesota. Petitioner is a stock brokerage firm which provided the services usually offered by such firms to their clients. Petitioner’s sole shareholder is Jack W. Pagel.

In September 1977, petitioner served as underwriter for a stock offering by Immuno Nuclear Corp. (Immuno). In the stock offering, 235,000 Immuno shares were sold at $1.50 per share, thus generating total proceeds of $352,500. Of that amount, Immuno received $310,200 and petitioner received $42,300 as commissions for the underwriting.

In connection with the underwriting, petitioner also received a warrant for the purchase of Immuno stock (the warrant). Petitioner paid Immuno a total of $10 for the warrant. Petitioner acquired the warrant pursuant to a clause in an underwriting agreement between Immuno and petitioner which provided that Immuno would sell to petitioner for $10 a warrant for (1) 17,000 Immuno shares, provided that petitioner sold at least 170,000 Immuno shares in the underwriting, or (2) 23,500 shares, in the event that petitioner sold all 235,000 shares made available in the offering.

The warrant provided that petitioner had the right to purchase 23,500 shares of Immuno common stock during the period beginning 13 months after October 5, 1977, the date of the warrant, and ending October 4, 1982, at the following prices per share:

If purchased after October 4, 1978,
If purchased thereafter and on or before October 4, 1980, at $1.710;
If purchased thereafter and on or before October 4, 1981, at $1.815;
If purchased thereafter until expiration at $1.920.

Petitioner’s right under the warrant to purchase the Im-muno stock was not conditioned upon the future performance of any services by petitioner. Petitioner, however, could not assign, transfer, hypothecate, sell, or otherwise dispose of the warrant during the first 13 months after October 5, 1977.

When petitioner received the warrant, there was no active trading of Immuno warrants on any established market. Petitioner held the warrant in a segregated investment account from the time it acquired the warrant (October 1977) until October 1981. On October 2, 1981, petitioner sold the warrant to its sole shareholder, Mr. Pagel, for $314,900. On its Federal corporate income tax return for the year ending March 31, 1982, petitioner reported the sale of the warrant as a capital gain in the amount of $314,890 (proceeds of $314,900 and basis of $10).

In the notice of deficiency, respondent recharacterized the gain from the sale of the warrant as ordinary income, based upon the following explanations:

li. Schedule D (Capital Gains and Losses)
Since you were the underwriter for [Immuno] and were afforded the right to purchase their stock warrants at a bargain purchase price, your sale of these stock warrants should be reported as ordinary income. Therefore, we have not allowed capital gain treatment for the $314,890 gain resulting from the sale of these stock warrants.
lj. Underwriting Income
Ordinary income was increased * * * to reflect the sale of stock warrants of [Immuno] * * * . You were the underwriters * * * , and were afforded the right to purchase their stock warrents [sic] at a bargain purchase price. Therefore, you should recognize ordinary income at the time of exercise or transfer of the option in the amount of the difference between the fair market value and the exercise price.

OPINION

The issue is whether petitioner’s gain from the sale of the warrant to Mr. Pagel is taxable as ordinary income or as capital gain. Respondent asserts that section 833 governs the resolution of this case. He argues that, under section 83 and section 1.83-7, Income Tax Regs., $314,890 ($314,900 proceeds from petitioner’s sale of the warrant to Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Christopher Aubuchon
U.S. Tax Court, 2024
Eric Freeman
U.S. Tax Court, 2021
Moacir Santos v. Commissioner
2019 T.C. Memo. 148 (U.S. Tax Court, 2019)
Scott A. Householder & Debra A. Householder v. Commissioner
2018 T.C. Memo. 136 (U.S. Tax Court, 2018)
Silva v. Comm'r
2015 T.C. Memo. 229 (U.S. Tax Court, 2015)
Kline v. Comm'r
2015 T.C. Memo. 144 (U.S. Tax Court, 2015)
Chai v. Comm'r
2015 T.C. Memo. 42 (U.S. Tax Court, 2015)
Bergdale v. Comm'r
2014 T.C. Memo. 152 (U.S. Tax Court, 2014)
Chapman Glen Ltd. v. Commissioner
140 T.C. No. 15 (U.S. Tax Court, 2013)
Chapman Glen Limited v. Commissioner
140 T.C. No. 15 (U.S. Tax Court, 2013)
Riether v. United States
919 F. Supp. 2d 1140 (D. New Mexico, 2012)
Rolfs v. Comm'r
135 T.C. No. 24 (U.S. Tax Court, 2010)
Klaas v. CIR
Tenth Circuit, 2010
Estate of Gore v. Comm'r
2007 T.C. Memo. 169 (U.S. Tax Court, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
91 T.C. No. 18, 91 T.C. 200, 1988 U.S. Tax Ct. LEXIS 102, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pagel-inc-v-commissioner-tax-1988.